Cigna Group (NYSE:CI) Issues FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 30.450- for the period, compared to the consensus estimate of 30.400. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

CI has been the topic of several research reports. Guggenheim raised their target price on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. Robert W. Baird set a $337.00 price target on Cigna Group in a report on Friday, May 1st. Royal Bank Of Canada lifted their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. Finally, Piper Sandler lowered their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Stock Performance

CI traded down $8.91 during trading on Thursday, hitting $287.56. The stock had a trading volume of 2,320,486 shares, compared to its average volume of 1,680,586. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The firm has a market capitalization of $76.07 billion, a P/E ratio of 12.19, a PEG ratio of 1.16 and a beta of 0.29. The company’s 50-day moving average price is $286.64 and its 200 day moving average price is $281.06.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period in the previous year, the firm posted $7.20 earnings per share. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported second-quarter adjusted earnings of $7.78 per share, exceeding the $7.60 consensus estimate and rising from $7.20 a year earlier. Revenue increased approximately 7% year over year to about $71.7 billion. CI Q2 Earnings Beat Estimates on Cigna Healthcare Strength
• Positive Sentiment: The company raised its 2026 adjusted earnings outlook to at least $30.45 per share, slightly above the roughly $30.40 analyst consensus. Growth was broad-based, with Cigna Healthcare revenue up 9% and Evernorth Health Services revenue up 6% year over year. Cigna raises annual profit forecast on strength in health services unit
• Neutral Sentiment: Net income reached nearly $1.7 billion, or $6.29 per share, while adjusted operating income was $2.1 billion. The results indicate continued operating strength, although reported revenue was modestly below one estimate of $70.14 billion, depending on the company’s reporting measure used. The Cigna Group Reports Strong Second Quarter 2026 Results
• Negative Sentiment: Management expects lower growth in prescriptions for popular GLP-1 drugs, while higher pharmacy costs remain a concern. Those comments appear to be tempering the market’s reaction to the earnings beat and guidance increase. Cigna Expects Lower Growth in Popular GLP-1 Drug Prescriptions

Institutional Trading of Cigna Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the 4th quarter valued at about $25,000. Prosperity Bancshares Inc bought a new position in Cigna Group during the fourth quarter worth about $29,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group in the fourth quarter valued at approximately $29,000. Measured Wealth Private Client Group LLC bought a new position in shares of Cigna Group in the third quarter worth $56,000. Finally, Johnson Financial Group Inc. increased its holdings in Cigna Group by 445.9% in the 3rd quarter. Johnson Financial Group Inc. now owns 202 shares of the health services provider’s stock valued at $58,000 after buying an additional 165 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.